rs3824090
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024915.4(GRHL2):c.*285C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 523,474 control chromosomes in the GnomAD database, including 15,127 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 4562 hom., cov: 32)
Exomes 𝑓: 0.23 ( 10565 hom. )
Consequence
GRHL2
NM_024915.4 3_prime_UTR
NM_024915.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.284
Publications
7 publications found
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
GRHL2 Gene-Disease associations (from GenCC):
- autosomal dominant nonsyndromic hearing loss 28Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AD Classification: STRONG Submitted by: ClinGen
- posterior polymorphous corneal dystrophyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
- nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital fibrosis of extraocular musclesInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 8-101666988-C-T is Benign according to our data. Variant chr8-101666988-C-T is described in ClinVar as Benign. ClinVar VariationId is 1261948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.277 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRHL2 | NM_024915.4 | c.*285C>T | 3_prime_UTR_variant | Exon 16 of 16 | ENST00000646743.1 | NP_079191.2 | ||
| GRHL2 | NM_001330593.2 | c.*285C>T | 3_prime_UTR_variant | Exon 16 of 16 | NP_001317522.1 | |||
| GRHL2 | NM_001440448.1 | c.*285C>T | 3_prime_UTR_variant | Exon 16 of 16 | NP_001427377.1 | |||
| GRHL2 | NM_001440447.1 | c.1763+2470C>T | intron_variant | Intron 15 of 15 | NP_001427376.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.241 AC: 36608AN: 151816Hom.: 4562 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
36608
AN:
151816
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.234 AC: 86758AN: 371540Hom.: 10565 Cov.: 0 AF XY: 0.237 AC XY: 46540AN XY: 196760 show subpopulations
GnomAD4 exome
AF:
AC:
86758
AN:
371540
Hom.:
Cov.:
0
AF XY:
AC XY:
46540
AN XY:
196760
show subpopulations
African (AFR)
AF:
AC:
3010
AN:
10856
American (AMR)
AF:
AC:
5178
AN:
16426
Ashkenazi Jewish (ASJ)
AF:
AC:
2576
AN:
11266
East Asian (EAS)
AF:
AC:
6103
AN:
23748
South Asian (SAS)
AF:
AC:
12986
AN:
44308
European-Finnish (FIN)
AF:
AC:
4623
AN:
21908
Middle Eastern (MID)
AF:
AC:
325
AN:
1580
European-Non Finnish (NFE)
AF:
AC:
47052
AN:
220176
Other (OTH)
AF:
AC:
4905
AN:
21272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
3393
6786
10178
13571
16964
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.241 AC: 36627AN: 151934Hom.: 4562 Cov.: 32 AF XY: 0.242 AC XY: 17990AN XY: 74244 show subpopulations
GnomAD4 genome
AF:
AC:
36627
AN:
151934
Hom.:
Cov.:
32
AF XY:
AC XY:
17990
AN XY:
74244
show subpopulations
African (AFR)
AF:
AC:
11651
AN:
41416
American (AMR)
AF:
AC:
4224
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
803
AN:
3470
East Asian (EAS)
AF:
AC:
1267
AN:
5140
South Asian (SAS)
AF:
AC:
1366
AN:
4800
European-Finnish (FIN)
AF:
AC:
2127
AN:
10562
Middle Eastern (MID)
AF:
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14553
AN:
67958
Other (OTH)
AF:
AC:
480
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1432
2864
4295
5727
7159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
915
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.